(Q54384589)

English

Amelioration of diabetes-induced cognitive deficits by GSK-3β inhibition is attributed to modulation of neurotransmitters and neuroinflammation.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24420785

Amelioration of diabetes-induced cognitive deficits by GSK-3β inhibition is attributed to modulation of neurotransmitters and neuroinflammation. (English)

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24420785

0 references

neurotransmitter

1 reference

based on heuristic

inferred from title

Ashok Kumar Datusalia

1

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24420785

author name string

Shyam Sunder Sharma

2

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24420785

publication date

14 January 2014

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24420785

Molecular Neurobiology

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24420785

50

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24420785

2

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24420785

390-405

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24420785

https://scigraph.springernature.com/pub.10.1007/s12035-014-8632-x

0 references

Global burden of disease--where does diabetes mellitus fit in?

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Mental health issues in adolescents and young adults with type 1 diabetes: prevalence and impact on glycemic control.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Diabetes and cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Alzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Cognitive dysfunction and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Obesity and hypertriglyceridemia produce cognitive impairment

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Insulin resistance in cognitive impairment: the InCHIANTI study.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Activator or inhibitor? GSK-3 as a new drug target

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Extension of a new two-trial memory task in the rat: influence of environmental context on recognition processes.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Applications of the Morris water maze in the study of learning and memory

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Chronic (-) deprenyl administration increases dendritic arborization in CA3 neurons of hippocampus and AChE activity in specific regions of the primate brain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Self-stimulation of lateral hypothalamus and ventral tegmentum increases the levels of noradrenaline, dopamine, glutamate, and AChE activity, but not 5-hydroxytryptamine and GABA levels in hippocampus and motor cortex.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Role of vibrissae for depth perception in the rat (Rattus norvegicus)

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

PPARγ agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Cognitive dysfunction and diabetes: implications for primary care.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

PPARγ agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Improving metabolic control leads to better working memory in adults with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Insulin and the insulin receptor in experimental models of learning and memory.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

A pivotal role of GSK-3 in synaptic plasticity.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Neurological functions of the masterswitch protein kinase - gsk-3.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Diabetes synergistically exacerbates poststroke dementia and tau abnormality in brain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Function and regulation of CREB family transcription factors in the nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

A Functional Role for CREB as a Positive Regulator of Memory Formation and LTP.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Disruption of CREB function in brain leads to neurodegeneration

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Glycogen synthase kinase-3 represses cyclic AMP response element-binding protein (CREB)-targeted immediate early genes in quiescent cells

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Immune modulation of learning, memory, neural plasticity and neurogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Alloxan-diabetes alters kinetic properties of the membrane-bound form, but not of the soluble form, of acetylcholinesterase in rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Erythrocyte membrane acetylcholinesterase in type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Glutamate uptake

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Metabotropic glutamate receptors in hippocampal long-term potentiation and learning and memory

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Brain glycogen and its role in supporting glutamate and GABA homeostasis in a type 2 diabetes rat model.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Obesity and type 2 diabetes in rats are associated with altered brain glycogen and amino-acid homeostasis.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Astrocytic energetics during excitatory neurotransmission: What are contributions of glutamate oxidation and glycolysis?

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Prevalence and clinical characteristics of recently diagnosed type 2 diabetes patients with positive anti-glutamic Acid decarboxylase antibody

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Effects of GABA antagonists on inhibitory avoidance.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Hyperglycaemia and diabetes impair gap junctional communication among astrocytes

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8632-X

21 January 2018

Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments

1 reference

https://pubmed.ncbi.nlm.nih.gov/24420785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type 2 diabetes and cognitive impairment: linking mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/24420785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of diabetes with amnestic and nonamnestic mild cognitive impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24420785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

By the numbers: new estimates from the IDF Diabetes Atlas Update for 2012

1 reference

https://pubmed.ncbi.nlm.nih.gov/24420785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of streptozotocin-induced diabetes on tau phosphorylation in the rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/24420785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycogen synthase kinase 3: a point of integration in Alzheimer's disease and a therapeutic target?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24420785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance and Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24420785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades

1 reference

https://pubmed.ncbi.nlm.nih.gov/24420785

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12035-014-8632-X

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24420785

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24420785

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54384589&oldid=1420951733"